65 related articles for article (PubMed ID: 8742434)
1. Transport of hydrophobized fragments of antibodies through the blood-brain barrier.
Chekhonin VP; Ryabukhin IA; Zhirkov YA; Kashparov IA; Dmitriyeva TB
Neuroreport; 1995 Dec; 7(1):129-32. PubMed ID: 8742434
[TBL] [Abstract][Full Text] [Related]
2. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid acylated Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain.
Chekhonin VP; Kabanov AV; Zhirkov YA; Morozov GV
FEBS Lett; 1991 Aug; 287(1-2):149-52. PubMed ID: 1715283
[TBL] [Abstract][Full Text] [Related]
4. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.
Neuwelt EA; Barnett PA; Hellström I; Hellström KE; Beaumier P; McCormick CI; Weigel RM
Cancer Res; 1988 Sep; 48(17):4725-9. PubMed ID: 3409213
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
6. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
7. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.
Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T
J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501
[TBL] [Abstract][Full Text] [Related]
8. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.
Poduslo JF; Curran GL; Haggard JJ; Biere AL; Selkoe DJ
Neurobiol Dis; 1997; 4(1):27-34. PubMed ID: 9258909
[TBL] [Abstract][Full Text] [Related]
9. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
10. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.
Poduslo JF; Curran GL; Sanyal B; Selkoe DJ
Neurobiol Dis; 1999 Jun; 6(3):190-9. PubMed ID: 10408808
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
13. [Penetration of anti-cerebral antibodies through the blood-brain and placental barriers of animals].
Semenov SK; Maĭzelis MIa; Kogan RD; Trekova NA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):229-33. PubMed ID: 1266485
[TBL] [Abstract][Full Text] [Related]
14. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
16. Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region.
Maolood N; Meister B
J Chem Neuroanat; 2009 May; 37(3):182-95. PubMed ID: 19146948
[TBL] [Abstract][Full Text] [Related]
17. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head.
Hofman P; Hoyng P; vanderWerf F; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):895-901. PubMed ID: 11274064
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
Nonaka N; Shioda S; Banks WA
Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody.
Wu D; Pardridge WM
Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674
[TBL] [Abstract][Full Text] [Related]
20. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
Tachikawa M; Kasai Y; Yokoyama R; Fujinawa J; Ganapathy V; Terasaki T; Hosoya K
J Neurochem; 2009 Oct; 111(2):499-509. PubMed ID: 19682207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
